pcDNA3.1-hAsCpf1(TYCV) (pY210) Citations (3)
Originally described in: Engineered Cpf1 variants with altered PAM specificities.Gao L, Cox DBT, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F Nat Biotechnol. 2017 Jun 5. doi: 10.1038/nbt.3900. PubMed Journal
Articles Citing pcDNA3.1-hAsCpf1(TYCV) (pY210)
| Articles |
|---|
Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants.
Toth E, Czene BC, Kulcsar PI, Krausz SL, Talas A, Nyeste A, Varga E, Huszar K, Weinhardt N, Ligeti Z, Borsy AE, Fodor E, Welker E.
Nucleic Acids Res. 2018 Sep 20. pii: 5103950. doi: 10.1093/nar/gky815.
PubMed
Associated Plasmids |
| SAYSD1 senses UFMylated ribosome to safeguard co-translational protein translocation at the endoplasmic reticulum. Wang L, Xu Y, Yun S, Yuan Q, Satpute-Krishnan P, Ye Y. Cell Rep. 2023 Jan 31;42(1):112028. doi: 10.1016/j.celrep.2023.112028. Epub 2023 Jan 23. PubMed |
| RNA-mediated condensation of TFE3 oncofusions facilitates transcriptional hub formation to promote translocation renal cell carcinoma. Guo L, Zhao R, Lee YT, Huang J, Wengler J, Rivera L, Hong T, Wang T, Rathod K, Suris A, Wu Y, Cai X, Wang R, Zhou Y, Huang Y. Nat Commun. 2025 Sep 30;16(1):8712. doi: 10.1038/s41467-025-63761-z. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.